Alaunos Therapeutics Inc.

NASDAQ: TCRT · Real-Time Price · USD
2.06
-0.18 (-8.04%)
At close: Aug 20, 2025, 3:59 PM
2.05
-0.73%
Pre-market: Aug 21, 2025, 04:00 AM EDT

Alaunos Therapeutics Revenue

Alaunos Therapeutics reported an annual revenue of $10K, reflecting a 100% growth. For the quarter ending March 31, 2025, Alaunos Therapeutics generated $2K in revenue.
Revenue (ttm)
10K
Revenue Growth
100%
Price / Sales Ratio
305.84
Revenue / Employee
10K
Employees
1
Market Cap
4.09M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 10K +100.00%
Dec 31, 2023 5K -99.83%
Dec 31, 2022 2.92M +634.17%
Dec 31, 2021 398K +Infinity%
Dec 31, 2020 0 n/a
Dec 31, 2019 0 -100.00%
Dec 31, 2018 146K -97.71%
Dec 31, 2017 6.39M -6.88%
Dec 31, 2016 6.86M +58.38%
Dec 31, 2015 4.33M +215.51%
Dec 31, 2014 1.37M +71.63%
Dec 31, 2013 800K n/a
Dec 31, 2012 800K +19.94%
Dec 31, 2011 667K +Infinity%
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Dec 31, 2005 0 n/a
Dec 31, 2004 0 n/a
Dec 31, 2003 0 -100.00%
Dec 31, 2002 2.57K +48.90%
Dec 31, 2001 1.73K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.